eli lilly sues compounders for selling unapproved copies of tirzepatide just issued a public warning to the compounding industry. In a recent open letter, the pharmaceutical company raised concerns about products being combined with vitamin B12 and marketed in Lilly sues four compounders over

New Data: Phase 3 TRIUMPH-4 Results (Retatrutide) Eli Lilly just released topline results from the Phase 3 TRIUMPH-4 trial, evaluating the triple hormone receptor agonist retatrutide in patients with obesity and knee osteoarthritis (OA)

RTA Peptide available in 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg options

Clavulanate potassium fights bacteria that is often resistant to penicillins and other antibiotics

Understanding pharmacy credentials, quality assurance, and personalization frameworks supports informed medication decisions

The GLP-1 muscle loss scare pushed me into the gym at 50

Oral alternative to injectable semaglutide